Abstract
Bupivacaine, a sodium ion channel inhibitor, has a long history of clinical use in local anesthesia and pain management. However, its systemic toxicity, which can lead to adverse cardiac conditions, poses a significant challenge in clinics. In this study, we replaced the central piperidine ring of bupivacaine with three linear spirocyclic moieties and evaluated the effects of the resulting analogues using physicochemical tests and animal studies. We found that, despite being more hydrophobic than the parent drug, the analogues demonstrated an acceptable level of local anesthesia in mice. Notably, the spirocyclic structures exhibited significantly lower toxicity, with increases in the lethal doses of 1.3-, 2.2-, and 5.0-fold for the three tested structures, respectively. Animal studies suggested that this reduced toxicity may be attributed to lower cardiotoxicity, as evidenced by less QRS widening in isolated guinea pig hearts. Our results suggest that further exploration of spirocyclic analogues of local anesthetics is warranted and support the use of spirocyclic azetidines as a replacement for the piperidine ring in drugs.

This publication has 51 references indexed in Scilit: